Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2005

View Archived Issues

Data presented on the potential of KRP-203 in clinical transplantation

Minocycline accelerates the recovery of olfactory sensory neurons

mGluR5 antagonist MTEP demonstrates antiparkinsonian effects

Update on preclinical pharmacological profile of tanaproget

LGD-5552 exhibits potent antiinflammatory activity

TLR4 agonists trigger innate resistance in infectious challenge

Good results reported for the Cypher stent in complex CAD patients

Preliminary results on the efficacy of Tovaxin in multiple sclerosis

Promising phase I data on the effects and safety of BMS-188797 in solid malignancies

p38 MAP kinase: a target for pulmonary hypertension

Dual TACE/MMP inhibition is effective for arthritis

Revlimid NDA accepted for review

New license for use of paclitaxel in treatment of emphysema

Aegis Therapeutics enters into Intravail agreements

Meditech Pharmaceuticals to change name to Deli Solar

BioInvent and CAT sign license agreement

Pentoxifylline studied to stop progression of NASH

LCL-204 induces apoptosis in human prostate carcinoma cells

MorphoSys grants ImmunoGen access to HuCAL GOLD

Affitech grants license for Protein L

Boehringer Ingelheim and AbGenomics sign antibody agreement

Oxford BioMedica licenses LentiVector technology to Pfizer

Anatibant receives orphan drug designation for severe traumatic brain injury

Factive meets primary endpoint in phase III study of five-day CAP treatment

Ligand earns new milestone from GSK collaboration

Human embryonic stem cell-derived HSCs establish hematopoiesis in mice

Merck & Co. patents cover novel NR2B receptor antagonists

Recent Bayer patent describes new antiretroviral agents

New treatments for diabetes reported in recent patent literature

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...